Associate Director - Genetic Biomarker Discovery

Job expired!

Join Novo Nordisk as Associate Director - Human Genetics for Early Development

Location: Oxford or London, UK or Copenhagen, Denmark

Working Model: Hybrid (3 days from office), Annual Travel: 5-10%

Application Deadline: 7th July 2024

About the Position

We are seeking an innovative Associate Director of Human Genetics for Early Development to join our dynamic Human Genetics Centre of Excellence (CoE) team. You will lead the strategy and execution of biomarker discovery based on human genetics, multi-omics, and imaging.

In this role, you will drive genetically-led biomarker identification across all therapeutic areas. By integrating and analyzing large-scale human genetics and multi-omics datasets with state-of-the-art methodologies such as AI/ML, you will co-develop strategies for leveraging genetic data with the Vice President of the Human Genetics CoE. This includes using multi-omics, clinical phenotypes, imaging, and wearables data for identifying and validating novel biomarkers for early development programs.

Your Responsibilities

  • Lead and mentor a small team of scientists with expertise in human genetics in line with Novo Nordisk’s values.
  • Develop strong relationships with global stakeholders, particularly across the Human Genetics CoE, Computational Biology, and Global Translation teams.
  • Establish and maintain external partnerships with academic institutions, biotech companies, and consortia to generate relevant human genetic and multi-omics data.
  • Be an integral part of the Human Genetics CoE leadership team, promoting a motivated and happy work environment.
  • Communicate and present findings and recommendations to senior management and key stakeholders.

Qualifications

We are looking for a collaborative leader comfortable leading a global team and driving innovative ideas into impactful outcomes. Our ideal candidate will meet the following criteria:

  • PhD in genetics, bioinformatics, computational genetics, or a related field.
  • Several years of expertise in human genetics and leadership experience.
  • Proven track record in applying human genetics and multi-omics to biomarker discovery and drug development.
  • Strong knowledge and experience in using AI and machine learning models on biological data.
  • Proficiency in programming languages such as R, Python, MATLAB, or SAS.
  • Experience leading and managing a team of scientists and collaborating with cross-functional teams.
  • Experience working within a matrix environment.

About the Centre

You will join the leadership team of the Human Genetics CoE, led by Vice President Joanna Howson, PhD. Our focus is on using data science and human genetics to innovate the Novo Nordisk drug discovery and development pipeline. The Centre is part of the Digital Science & Innovation organization within the Research & Early Development (R&ED) SVP area.

Digital Science & Innovation (DSI) supports Novo Nordisk’s digital journey across all therapy areas in R&ED. We work in multidisciplinary teams and engage in drug development projects from early discovery to pre-clinical development. Our collaborations ensure access to the latest research and technology, and we automate labs and processes while focusing on developing and retaining top talent.

Working at Novo Nordisk

As a life-science company, life is our reason to exist. For employees at Novo Nordisk, life encompasses everything from scientific research to personal fulfillment. Our mission is to ensure people can lead lives independent of chronic disease.

We are committed to an inclusive recruitment process and equality of opportunity for all our job applicants.

Contact

To apply, please use our , as we do not accept direct resumes.

Join Us

At Novo Nordisk, we aim to be the best company not just in the world but for the world. This vision is only possible with diverse and talented employees. We are committed to creating an inclusive culture that celebrates diverse perspectives, backgrounds, and cultures. Together, we’re life-changing.